Advancements in omics-scale profiling technologies have ushered in new perspectives in immunology research and expanded our ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

In several disease conditions, including infections and cancers, innate immune activation and nutrient scarcity occur together.

Scientists led by Stephanie Eisenbarth, MD, Ph.D., the Roy and Elaine Patterson Professor of Medicine and director of the ...

While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...

Background Interstitial fibrosis in lupus nephritis (LN) is often infiltrated by immune cells but typically regarded as ...

Decitabine (DAC), a well-recognized DNA hypomethylating agent, has been applied to treat acute myeloid leukemia. However, clinic investigations revealed that DNA methylation reduction does not ...

Antimicrobial resistance (AMR) represents a rapidly growing concern at the intersection of environmental microbiology and ...

Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...

A new vaccine targeting the deadly Crimean-Congo hemorrhagic fever virus shows rapid protection in mice, working within days and lasting over a year.